APC and colonic neoplasm: Similar results were obtained in Study 2, where the number of Apc+/Min-FCCC mice without colon tumors was higher following administration of recMASH2+AS15 (11/47; 23%) than AS15 alone (8/52;15%) or PBS (5/46; 11%).